The Kimberley Prospector

Category: Global News

GSK enters agreement to acquire Nuvalent, Inc.

GSK enters agreement to acquire Nuvalent, Inc.

(“Nuvalent”) (NASDAQ: NUVL) a Boston-based clinical-stage biopharmaceutical company focused on creating precisely targeted oncology therapies, for … Read more: GSK enters agreement to acquire Nuvalent, Inc.

Back to top